secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001104659-23-079195
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health Stockholders Approve All Five Proposals at 2023 Annual Meeting
----------------------------------------------------------------------------

- Elected John Micek III as Class II director with 6,027,707 votes for.
- Ratified RBSM LLP as independent auditor for fiscal year 2023 with 8,608,787 votes for.
- Approved issuance of common stock upon exercise of warrants and conversion of preferred stock under Nasdaq rule 5635(d).
- Approved amendment to 2014 Stock Incentive Plan to increase authorized shares by 2,700,000 and extend term to 10 years.
- Approved discretionary authority to adjourn meeting if needed to solicit additional proxies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000110465923079195/0001104659-23-079195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000110465923079195/tm2320852d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-079195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer